February 09, 2023
Institutional Review Board, Hospital for Special Surgery
The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.
For further information, see Understanding Clinical Trials/Research Studies.
Preston W. Gross, BS
Yukiko Matsuzaki PT, DPT, OCS, SCS
Danielle E. Chipman
Daniel W. Green, MD, MS, FAAP, FACS
Kyle Kunze, MD
Athletes will be given Garmin Vivofit 4 wearables and will participate in preseason movement analysis tests. Athletes and coaches will complete short questionnaires periodically. Each subject will be followed up for the duration of their athletic season. 600 subjects will be enrolled in this study over the course of 2 years.
Inclusion criteria
Exclusion criteria:
Preston W. Gross, BS
grossp@hss.edu
646.714.6626
Yukiko Matsuzaki, PT, DPT
masuzakiy@hss.edu
212.606.4362
Peter D. Fabricant, MD, MPH
fabricantp@hss.edu
212.606.1996